The Beauty Health Company
Price Action
Technical Summary
WEAKENINGThe Beauty Health Company is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 14), showing significant lag compared to the market leaders. Earnings growth of 38% provides fundamental context to the price action. However, price is extended 53% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.69 | +60.24% | ABOVE |
| 50 SMA | $0.72 | +53.44% | ABOVE |
| 100 SMA | $0.86 | +28.67% | ABOVE |
| 150 SMA | $1.06 | +4.45% | ABOVE |
| 200 SMA | $1.19 | -6.39% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is SKIN in an uptrend right now?
SKIN has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is SKIN overbought or oversold?
SKIN's RSI (14) is 60. The stock is in neutral territory, neither overbought nor oversold.
Is SKIN outperforming the market?
SKIN has a Relative Strength (RS) Rating of 14 out of 99. SKIN is currently lagging the broader market.
Where is SKIN in its 52-week range?
SKIN is trading at $1.11, which is 41% of its 52-week high ($2.69) and 26% above its 52-week low ($0.55).
How volatile is SKIN?
SKIN has a Beta of 1.76 and 52-week volatility of 90%. It's more volatile than the S&P 500 - expect bigger swings.